CytomX Therapeutics Inc (CTMX) is higher by Monday morning, with the stock rising 3.50% in pre-market trading to 1.48. CTMX's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 75 out of 146 industries, CytomX Therapeutics Inc ranks higher than 30% of stocks. CytomX Therapeutics Inc has fallen 22.28% over the past month, closing at $1.94 on July 4. During this period of time, the stock fell as low as $1.23 and as high as $2.01. CTMX has an average analyst recommendation of Buy. The company has an average price target of $3.95.
CytomX Therapeutics Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 106 by this metric, CTMX ranks better than 106% of stocks.
CytomX Therapeutics Inc (CTMX) Up 3.50% in Premarket Trading
CTMX has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on CTMX!